Best Practices: Ultrasound Versus MRI in the Assessment of Pelvic Endometriosis

review OA: closed CC0 ⤵ 11 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This review found that dedicated ultrasound and MRI showed similar diagnostic accuracy for pelvic endometriosis, with modality choice depending on regional expertise, though ultrasound better assessed bowel-wall invasion and MRI pelvic-wall disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a common yet morbid disease. Imaging plays an important role in diagnosis and treatment planning. Both ultrasound (US) and MRI are used to detect disease. We performed a literature review to assess whether one is superior. A total of 33 studies from the 4482 identified in the initial search were found to assess the efficacy of US and/or MRI in detecting pelvic endometriosis. Most studies were performed at centers with extensive experience with endometriosis, using dedicated US and MRI protocols. A wide range of sensitivities and specificities were reported, but overall weighted means of diagnostic statistics for US and MRI were similar. The choice of dedicated US versus dedicated MRI in the evaluation of endometriosis should therefore be based on the expertise in the region. The data also showed US had better accuracy than MRI for identifying the depth of wall invasion in bowel-wall disease, whereas MRI better depicted pelvic-wall and extraperitoneal disease than US. Routine US and MRI protocols performed worse than dedicated US and MRI protocols, which may account for delays in diagnoses. Clinical and research efforts directed at improving the sensitivity of routine imaging for diagnosing deep endometriosis could improve patient access to appropriate care.
Full text 9,133 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Clinical Vignettes and Images The Imaging Question

Background

Epidemiology Imaging Appearance Role of Imaging Imaging Techniques | Sequence | Plane or FOV | |---|---| | T2-weighted TSE without FS | Axial (including small FOV) and sagittal, with or without coronal | | T1-weighted GRE in- and opposed-phase | Axial | | DWI with ADC mapping | Axial | | T1-weighted GRE with FS without IV contrast material | Axial and sagittal, with or without coronal | | T1-weighted GRE with FS with IV contrast material and subtraction | Axial and sagittal, with or without coronal | | T2-weighted SSFSE (optional) | Large FOV that includes the kidneys for evaluation of hydronephrosis | Note—TSE = turbo spin-echo, FS = fat suppression, GRE = gradient-recalled echo. Synopsis and Synthesis of Evidence Literature Review | First Author [Reference] | Year | Risk of Bias | Applicability Concerns | ||||| |---|---|---|---|---|---|---|---|---| | Patient Sel | Index Test | Ref | Flow and Timing | Patient Sel | Index Test | Ref | || | Alborzi [21] | 2018 | High | High | High | High | High | High | High | | Alborzi [20] | 2023 | High | High | High | High | High | High | High | | Asgari [22] | 2022 | Low | UC | Low | UC | Low | Low | Low | | Bartlett [23] | 2020 | Low | Low | High | Low | Low | Low | Low | | Bazot [25] | 2009 | Low | Low | UC | UC | Low | Low | Low | | Bazot [24] | 2012 | Low | Low | High | UC | Low | Low | Low | | Chamié [26] | 2009 | Low | Low | UC | UC | Low | Low | Low | | Deslandes [27] | 2023 | Low | Low | High | High | Low | Low | Low | | Di Giovanni [28] | 2022 | Low | Low | UC | UC | Low | Low | Low | | Fratelli [29] | 2013 | Low | Low | High | Low | Low | Low | Low | | Goncalves [30] | 2021 | Low | Low | Low | UC | Low | Low | Low | | Guerriero [31] | 2008 | Low | Low | High | Low | Low | Low | Low | | Hernández Gutiérrez [32] | 2019 | Low | Low | UC | Low | Low | Low | Low | | Holland [33] | 2013 | Low | Low | Low | UC | Low | Low | Low | | Hudelist [34] | 2011 | Low | Low | High | Low | Low | Low | Low | | Kamkarfar [35] | 2022 | Low | UC | Low | UC | Low | Low | Low | | Krüger [36] | 2013 | Low | Low | High | Low | Low | Low | Low | | Manganaro [37] | 2012 | Low | UC | UC | UC | Low | Low | Low | | Mangler [38] | 2013 | Low | Low | UC | Low | Low | Low | Low | | Manti [39] | 2022 | Low | Low | UC | UC | Low | Low | Low | | Padmehr [40] | 2023 | High | High | High | UC | Low | Low | Low | | Pateman [41] | 2015 | Low | Low | High | UC | Low | Low | Low | | Pattanasri [42] | 2020 | Low | Low | High | UC | Low | Low | Low | | Piketty [43] | 2009 | Low | Low | UC | UC | Low | Low | Low | | Roditis [44] | 2023 | High | Low | UC | Low | Low | Low | Low | | Savelli [45] | 2009 | Low | High | High | Low | Low | Low | Low | | Savelli [46] | 2012 | Low | Low | High | UC | Low | Low | Low | | Siddiqui [47] | 2021 | High | Low | UC | UC | Low | Low | Low | | Sillou [48] | 2015 | High | Low | UC | UC | Low | Low | Low | | Stoppa [49] | 2023 | Low | Low | High | Low | Low | Low | Low | | Yap [16] | 2018 | Low | Low | High | Low | Low | Low | Low | | Yin [50] | 2020 | High | Low | UC | Low | Low | Low | Low | | Zhang [51] | 2019 | High | Low | UC | Low | Low | Low | Low | Note—Determinations were made by consensus of two reviewers. Sel = selection, Ref = reference standard, UC = unclear. | Modality, First Author [Reference] | Year | Department | No. of Patients | Sensitivity (%) | Specificity (%) | |---|---|---|---|---|---| | US | ||||| | Asgari [22] | 2022 | Gyn | 119 | 74.5a | 80.0a | | Deslandes [27] | 2023 | Rad | 53 | 84.0b | 89.3b | | Di Giovanni [28] | 2022 | Gyn | 4983 | 98.1c | 99.0c | | Fratelli [29] | 2013 | Gyn | 420 | 53.6c | 94.63c | | Goncalves [30] | 2021 | Rad | 120 | 88.5a | 94.23a | | Guerriero [31] | 2008 | Gyn | 88 | 62.7c | 92.3c | | Holland [33] | 2013 | Gyn | 198 | 52.2c | 98.7c | | Hudelist [34] | 2011 | Gyn | 129 | 78.8c | 84.2c | | Kamkarfar [35] | 2022 | Gyn | 80 | 71.0b | 96.4b | | Padmehr [40] | 2023 | Gyn | 170 | 58.8a | 67.8a | | Pateman [41] | 2015 | Gyn | 166 | 92.3b | 100.0b | | Pattanasri [42] | 2020 | Gyn | 119 | 49.1c | 88.2c | | Piketty [43] | 2009 | Gyn | 134 | 90.7b | 96.5b | | Savelli [45] | 2009 | Gyn | 490 | 44.0b | 100.0b | | Savelli [46] | 2012 | Gyn | 381 | 64.7 (88/136)b | 96.3 (236/245)b | | Yin [50] | 2020 | Rad | 198 | 85.9c | 90.8c | | Zhang [51] | 2019 | Rad | 118 | 95.3b | 90.9b | | MRI | ||||| | Bazot [24] | 2012 | Rad | 83 | 83.3b | 98.6b | | Chamié [26] | 2009 | Rad | 92 | 79.6c | 93.7c | | Krüger [36] | 2013 | Rad | 152 | 78.0c | 79.2c | | Manganaro [37] | 2012 | Rad | 46 | 97.0b | 100.0b | | Mangler [38] | 2013 | Gyn | 79 | 41.0b | 83.0b | | Manti [39] | 2022 | Rad | 72 | 86.9a | 96.0a | | Siddiqui [47] | 2021 | Rad | 170 | 86.7 (85/98)b | 81.9 (59/72)b | | Sillou [48] | 2015 | Rad | 35 | 91.022b | 59.0b | | Stoppa [49] | 2023 | Rad | 77 | 80.0b | 35.0b | | Yap [16] | 2018 | Rad | 37 | 76.9 (103/134)b | 98.5 (451/458)b | | US and MRI | ||||| | Alborzi [21] | 2018 | Gyn | 317 | || | US | 83.3 (210/252)b | 46.1 (30/65)b | ||| | MRI | 90.4b | 66.1b | ||| | Alborzi [20] | 2023 | Gyn | 555 | || | US | 56.9a | 84.9a | ||| | MRI | 47.4a | 73.7a | ||| | Bartlett [23] | 2020 | Rad | 83 | || | US | 22b | — | ||| | MRI | 61b | — | ||| | Bazot [25] | 2009 | Rad | 92 | || | US | 74.3c | 187.9c | ||| | MRI | 82.9c | 90.3c | ||| | Hernández Gutiérrez [32] | 2019 | Gyn | 48 | || | US | 62.0a | 80.3a | ||| | MRI | 57.2a | 80.8a | ||| | Roditis [44] | 2023 | Rad | 178 | || | US | 69.7c | 91.3c | ||| | MRI | 56.6c | 64.1c | ||| | Weighted mean | ||||| | US studies | ||||| | All | 82.9c | 94.2c | ||| | Excluding outlierd | 65.1c | 88.5c | ||| | MRI studies | 69.0c | 76.1c | Note—Dash (—) indicates value could not be calculated. Raw data for some performance measures are shown in parentheses. US = ultrasound, Gyn = gynecology, Rad = radiology. | Studies Stratified by Imaging Modality, Performance Measure | Ovary | Bladder, VUP, Anterior CDS | Ureters | Pelvic SW, Ovarian Fossa | Vagina, RV Septum | PM, USLs, RC, Torus Uterinus | RS | |---|---|---|---|---|---|---|---| | No. of studies with US only | 9 | 9 | 4 | 3 | 7 | 13 | 11 | | No. of studies with MRI only | 3 | 4 | 4 | 1 | 4 | 6 | 4 | | No. of studies with US and MRI | 2 | 4 | 2 | 3 | 4 | 6 | 6 | | All US studies | ||||||| | Sensitivity (%) | ||||||| | All studies | 77.5 (35.0–100.0) | 56.8 (0.0–100.0) | 64.7 (0.0–100.0) | 39.0 (3.8–84.0) | 60.8 (34.0–86.4) | 82.3 (1.8–98.1) | 73.7 (0.0–100.0) | | Excluding outliera | 56.9 (1.8–96.5) | |||||| | Specificity (%) | ||||||| | All studies | 84.4 (60.0–100.0) | 99.4 (0.0–100.0) | 99.3 (94.5–100.0) | 87.4 (74.7–100.0) | 95.5 (88.0–100.0) | 93.0 (0.5–99.0) | 92.5 (44.4–100.0) | | Excluding outliera | 82.9 (0.5–99.2) | |||||| | All MRI studies | ||||||| | Sensitivity (%) | 67.8 (56.9–97.0) | 73.0 (9.4–100.0) | 82.1 (0.0–100.0) | 63.6 (33.4–66.9) | 69.9 (41.0–100.0) | 60.0 (30.2–100.0) | 68.6 (13.0–100.0) | | Specificity (%) | 83.2 (73.6–96.9) | 99.0 (94.7–100.0) | 97.5 (59.0–100.0) | 66.0 (45.7–98.1) | 89.3 (78.5–100.0) | 80.0 (35.0–100.0) | 87.4 (77.5–96.6) | Note—Except where otherwise indicated, values are weighted means with the range in parentheses. US = ultrasound, VUP = vesicouterine pouch, CDS = cul-de-sac, SW = sidewall, RV = rectovaginal, PM = parametria, USL = uterosacral ligament, RC = retrocervical, RS = rectosigmoid. | Studies Stratified by Imaging Modality, Performance Measure | East Asia and/or South Asia | Australia | Europe | West Asia | North America | South America | |---|---|---|---|---|---|---| | No. of studies with US only | 2 | 2 | 9 | 3 | 0 | 1 | | No. of studies with MRI only | 1 | 1 | 7 | 0 | 0 | 1 | | No. of studies with US and MRI | 0 | 0 | 3 | 2 | 1 | 0 | | US studies | |||||| | Sensitivity (%) | |||||| | All | 89.4 (85.9–95.3) | 59.9 (49.1–84.0) | 86.4 (44.0–98.1) | 66.5 (56.9–83.3) | 8.1 | 88.5 | | Excluding outliera | 61.5 (44.0–74.3) | ||||| | Specificity (%) | |||||| | All | 90.8 (90.8–90.9) | 88.6 (88.2–89.3) | 97.9 (80.3–100.0) | 72.9 (46.1–96.4) | — | 94.2 | | Excluding outliera | 95.4 (80.3–100.0) | ||||| | MRI studies | |||||| | Sensitivity (%) | 86.7 | 76.9 | 72.5 (41.0–86.9) | 63.0 (47.4–90.4) | 41.2 | 64.2 | | Specificity (%) | 81.9 | 98.5 | 77.3 (0.35–96.0) | 70.9 (66.1–73.7) | — | 97.0 | Note—Except where otherwise indicated, values are weighted means with the range in parentheses. The location of the study was defined as the location of the first author's affiliation. Dash (—) indicates value could not be calculated. US = ultrasound. Superficial Endometriosis Endometriomas DE Evidence-Based Recommendations Outstanding Issues That Warrant Research Summary Recommendations for Best Practices Recommendations for Further Research Acknowledgment Footnotes Supplemental Content - Download - 829.05 KB

References

Information & Authors Information Published In Copyright History

Keywords

Authors Metrics & Citations Metrics Citations Export Citations To download the citation to this article, select your reference manager software.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Cited by (13)

Source provenance

europepmc
last seen: 2026-08-03T06:10:56.557307+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-08-03T06:08:40.855122+00:00
License: CC0 · commercial use OK